De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.
about
A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 targetReconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells.Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways.Revealing nascent proteomics in signaling pathways and cell differentiation.
P2860
De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@ast
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@en
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@nl
type
label
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@ast
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@en
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@nl
prefLabel
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@ast
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@en
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@nl
P2093
P2860
P356
P1476
De Novo proteome analysis of g ...... alkyne cycloaddition approach.
@en
P2093
Jennifer Lee
Johannes Gebert
Jürgen Kopitz
Seda Ballikaya
Uwe Warnken
P2860
P304
P356
10.1074/MCP.M113.036665
P577
2014-09-15T00:00:00Z